National Tender Systems - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

National Tender Systems

Description:

(b) Tender commission, Acts on advice from. scientific advisory group ... firms invited to tender. A. Expressions of ... in advertisement or tender document ... – PowerPoint PPT presentation

Number of Views:45
Avg rating:3.0/5.0
Slides: 40
Provided by: Debb296
Category:

less

Transcript and Presenter's Notes

Title: National Tender Systems


1
National Tender Systems
  • An Overview
  • Brian OMahony
  • WFH Global Forum
  • Montreal,
  • September 2005

2
  • Steps in a Tender Process
  • Procurement Rules
  • Tender Commissions
  • Selection Criteria
  • Examples
  • Advantages, Disadvantages

3
Developing a Tender Process
  • Decide on Contracting Authority
  • Establish Tender Commission
  • Single, Dual Tier
  • Composition
  • Terms of Reference
  • Product Remit
  • Reporting Relationships
  • Procedures
  • Liability

4
Tender Commissions
  • Model 1 - 2 Tier
  • (a) Scientific advisory group
  • (b) Tender commission, Acts on advice from
  • scientific advisory group
  • - Brazil, Uruguay
  • - Degree of overlap essential
  • Model 2 - Single integrated commission
  • - Ireland, England, Canada

5
Tender Process
  • A. Does tender fall within remit of the
    commission
  • - Products
  • - Thresholds
  • B. Category of Product Specified
  • - Plasma Derived
  • - Recombinant
  • - Both

6
Tender Process
  • C. Type of Tender Procedure
  • - National Procurement Rules
  • - EU Tenders
  • E.U. Directive 2004 / 18 / EC
  • Government Departments / Agencies
  • with gt 50 funding from government

7
EU Tender
  • Criteria
  • - Price
  • - Most Economically Advantageous (MEAT)
  • Methods
  • - Open - Competitive Dialogue
  • - Restricted - Negotiated

8
  • Open - Any company may apply
  • Restricted - Specific elements of design /
  • intellectual input required
  • - Particular firms invited to
    tender
  • A. Expressions of interest
  • B. Tender documents sent to qualifying
  • companies

9
  • Competitive Dialogue
  • - Pre qualified by restricted procedure
  • - Dialogue with minimum of 3 companies
  • - MEAT Criteria
  • Negotiated
  • - Exceptional circumstances
  • - Only 1 suitable company
  • - No tenders / irregular tenders received

10
Tender Process
  • D. Selection Criteria
  • - Price
  • - Most economically advantages (MEAT)
  • - Number of suppliers

11
Most Economically Advantageous Tender
  • Tender scored against pre stated criteria
  • Criteria stated in advertisement or tender
    document
  • Detailed criteria and weighings listed or in
    descending order of importance

12
MEAT-Selection Criteria
  • Safety, Quality, Efficacy
  • Supply
  • Cost
  • Scientific, Technical Support
  • Range of Products
  • Consumer, Physician preference
  • Mix of Products

13
Tender Process
  • E. Score Sheets
  • - Use selection criteria to assign
    scores and
  • weighing factors to each criteria, sub
    criteria
  • - Price is a criteria
  • - Prepared prior to receiving tenders
  • - Include in tender document

14
Criteria Score Sheets
  • Ireland
  • Recombinant FVIII, FIX 2003
  • Safety - 80
  • Efficacy - 30
  • Purity - 9
  • Supply/Availability - 18
  • Scientific Support - 10
  • Cost - 8

15
Recombinant FVIII, FIX 2003
  • Safety - Albumin as stabiliser
  • - Protein in culture medium
  • - Murine MAB
  • - Viral inactivation
  • - Inhibitors
  • - Other
  • Efficacy - Recovery
  • - Clinical Response

16
Recombinant FVIII, FIX 2003
  • Supply/Availability
  • - Number manufacturing plants
  • - Security of supply
  • Scientific Support
  • - Clinical opinion
  • - Consumer opinion
  • - Tender documentation
  • Cost

17
Tender Process
  • F. Quantity Purchased, Term of Tender
  • - Clinical requirements over specified
    time
  • period
  • - Build in flexibility
  • Minimum purchase
  • Option to purchase additional amount
  • Variation
  • - Term
  • 3 months 3 years

18
Tender Process
  • G. Process and Timelines
  • - Time limit for expressions of interest
  • - Time limit for receipt of tenders
  • H. Receipt of Tenders
  • - Time, date stamped
  • - Procedures for opening tenders
  • - No late receipt

19
Tender Process
  • I. Tender Commission
  • - Confirm valid tenders
  • - Seek clarification, further information
    if
  • required
  • - Presentations based on criteria, optional

20
Tender Process
  • I. Tender Commission
  • - Criteria may not be altered post tender
  • documents
  • - No post tender negotiation on price
  • - Additional information, time, deadlines to
    all
  • companies

21
Tender Process
  • J. Decision
  • - Score each product for each sub criteria
    on score
  • sheets
  • - Rationale for scores noted
  • - 1 Stage Score all criteria
  • - 2 Stage Score all criteria except price
  • - Products which meet required standard for
  • safety, efficacy, criteria, then scored
    on price

22
Tender Process
  • K. Communications of Decision
  • - Decision communicated without delay
  • - Short interval before contacts awarded
  • - Debriefing meeting with companies

23
Tender Process
  • L. Publication of Results
  • - EU, within 48 days
  • M. Conflict of Interest Policy
  • N. Disclosure of Information
  • - Confidential information
  • - Confidentiality agreements
  • - Freedom of information legislation

24
Tender Process
  • O. Committee Work Between Tenders
  • - Reports on product use, adverse events
  • - New information on products
  • - International trends
  • - Depends on Terms of Reference

25
Ireland
  • - HPSMAB Statutory
  • - Clinicians, I.H.S., Regulator, Virologist
  • Blood Transfusion, Government Officials,
  • Contracting Authority
  • - Score Sheets
  • - Number of supplies specified

26
Ireland
  • - Company presentations
  • - Debriefing meetings
  • - Monitoring of developments regularly

27
Canada
  • - Selection advisory committee
  • appointed by CBS
  • - Legal, safety, regulatory, procurement
  • expertise
  • - CHS, Immune deficiency organisation
  • - Clinicians

28
Canada
  • - Score sheets
  • - Meetings with companies
  • - Number of suppliers specified
  • - 90-95 requirements met by tender

29
England
  • - Committee under auspices of purchase and
  • supply agency PASA
  • - PASA, Clinicians, Haemophilia Society,
  • Regional Health Authorities.
  • - MEAT Criteria
  • - Each centre director may select products
  • they wish to use

30
Brazil
  • - Ministry of health / ANVISA
  • - 2 Tier System
  • Tender commission officials
  • Workgroups on coagulopathies
  • - 6 Clinicians
  • - 1 Haemophilia Society

31
Brazil
  • Workgroup on Coagulopathies
  • - Specify safety, efficacy, purity
  • - Specify type of concentrates to purchase
  • Commission
  • - Advertise, handle tender process
  • - Decide

32
Brazil
  • - No overlap between tiers
  • - Technical criteria not always followed
  • - Operation Vampire

33
Uruguay
  • - Tender committee appointed by Minister
  • for Health
  • - Officials Accountant, Notary
  • - 2 Technical Advisors
  • Set criteria on safety, efficacy, purity

34
Uruguay
  • - Technical advisors, advise
  • - Tender committee, decides
  • - Overlap communication at all stages
  • - If specified criteria met, final decision
    on price

35
National Tenders - Advantages
  • Broad Based Tender Commission with
  • Appropriate Expertise
  • - Better award criteria
  • - Better analysis of criteria
  • - More expertise than individual hospitals,
  • clinicians, officials, insurance companies

36
National Tenders - Advantages
  • - Improved comparative assessment of the
  • products
  • - Price placed realistically on list of
    criteria
  • not sole criteria
  • weighing depends on resources
  • - Assists in development of higher
    standards of care nationally

37
National Tenders - Advantages
  • - National assessment of demand and use
  • - National budget
  • - Cost effective
  • - Contingency Planning flexibility
  • - Stakeholder Buy-In

38
National Tenders - Disadvantages
  • - Limits range of products available
  • Number of suppliers
  • Clinicians may use other licensed
    products
  • - Limits clinical freedom
  • - Unsuccessful company may withdraw
    from country
  • Limiting future choice

39
  • Formal involvement by leading clinicians and
  • National Haemophilia Organisations in Tender
  • Committee is vital
  • - Selection criteria
  • - Knowledge based decisions
  • - Confidence
Write a Comment
User Comments (0)
About PowerShow.com